The digital health field continues to boom as SoftBank-backed startup hits unicorn status in SPAC reverse merger
Editor’s note: Interested in following biopharma’s fast-paced IPO market? You can bookmark our IPO Tracker here.
At the intersection of medicine and cutting-edge technology, the broad field of digital health has seen booming valuations in recent months with some big-name investors jumping in. Now, a company working on software-based therapeutics has leaped to unicorn status and will take its show on the road to Nasdaq.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.